The majority of genetic mutations seen in patients with HHT involve the activin-A receptor like type 1 (ACVRL1 or ALK1) and endoglin (ENG), which are TGF-β family cell surface receptors (5, 12). This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.